Immune Therapies for Myelodysplastic Syndromes and Acute Myeloid Leukemia

SIMPLE SUMMARY: Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) are bone marrow cancers that have a poor prognosis. They have traditionally been treated with chemotherapy with limited success, and stem cell transplant, which many patients are too frail to receive. Perturbations in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapoor, Sargam, Champion, Grace, Basu, Aparna, Mariampillai, Anu, Olnes, Matthew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507987/
https://www.ncbi.nlm.nih.gov/pubmed/34638510
http://dx.doi.org/10.3390/cancers13195026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507987/
https://www.ncbi.nlm.nih.gov/pubmed/34638510
http://dx.doi.org/10.3390/cancers13195026

Ejemplares similares